Andrew Capen
Impact in
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 3
- DNA Repair Mechanisms 2
- Oncology 7
- Lung Cancer Research Studies 3
- Cancer Immunotherapy and Biomarkers 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Bruce W. Konicek (4 shared papers)Sandaruwan Geeganage (3 shared papers)Lillian Sams (2 shared papers)Philip W. Iversen (3 shared papers)Jeremy R. Graff (2 shared papers)Thomas J. Brown (1 shared paper)Ann M. McNulty (1 shared paper)Blake Lee Neubauer (1 shared paper)
- Journals
- Cancer Research (9 papers)Molecular Cancer Therapeutics (3 papers)Clinical Cancer Research (1 paper)Journal of Thoracic Oncology (1 paper)ESMO Open (1 paper)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Andrew Capen
18 papers receiving 711 citations
Peers
Comparison fields: 5 of 79
- Genetics 121
- Oncology 212
- Molecular Biology 511
- Cancer Research 89
- Pathology and Forensic Medicine 103
Countries citing papers authored by Andrew Capen
This map shows the geographic impact of Andrew Capen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Capen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Capen more than expected).
Fields of papers citing papers by Andrew Capen
This network shows the impact of papers produced by Andrew Capen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Capen. The network helps show where Andrew Capen may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Capen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 362 | |
| 2 | 2015 | 91 | |
| 3 | 2014 | 45 | |
| 4 | 2011 | 43 | |
| 5 | 2018 | 38 | |
| 6 | 2021 | 37 | |
| 7 | 2011 | 31 | |
| 8 | 2015 | 30 | |
| 9 | 2013 | 13 | |
| 10 | 2018 | 8 | |
| 11 | 2024 | 7 | |
| 12 | 2006 | 5 | |
| 13 | 2018 | 4 | |
| 14 | 2017 | 3 | |
| 15 | 2019 | 3 | |
| 16 | 2017 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2016 | 1 | |
| 19 | 2023 | 0 |
About Andrew Capen
Andrew Capen is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Genetics, having authored 19 papers that have together received 724 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (4 papers), Lung Cancer Research Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer Research and Treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cancer-related Molecular Pathways (2 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Genetics (121 citations), Oncology (212 citations), Molecular Biology (511 citations), Cancer Research (89 citations) and Pathology and Forensic Medicine (103 citations). Andrew Capen has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Bruce W. Konicek, Sandaruwan Geeganage, Lillian Sams, Philip W. Iversen, Jeremy R. Graff, Thomas J. Brown, Ann M. McNulty, Blake Lee Neubauer, Luna Musib and Robert M. Campbell. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Clinical Cancer Research, Journal of Thoracic Oncology and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.